+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 60Years
All Genders
ID04897516

Phase III Study Comparing Shorter 2- and 4-Week Benznidazole Treatments to the Standard 8-Week Regimen for Adults With Chronic Chagas Disease

Led by Laboratorio Elea Phoenix S.A. · Updated on 2023-11-30

300

Participants Needed

6

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Chagas disease is a parasitic infection caused by Trypanosoma cruzi, affecting millions worldwide, especially in Latin America. Current treatments with benznidazole and nifurtimox have significant side effects and long durations, making it difficult for many adults to complete therapy. This study evaluates whether shorter treatment plans of 14 and 28 days with benznidazole are as effective as the standard 60-day course, aiming to improve safety and treatment completion rates in adults with chronic Chagas disease in its indeterminate or mild cardiac forms. Participants will be randomly assigned to one of three groups receiving benznidazole at 300 mg daily divided into three doses a 2-week regimen, a 4-week regimen, or the standard 8-week regimen. The study is a Phase III, multicenter, randomized trial comparing the efficacy and safety of these three treatment durations. The two shorter regimens are experimental, while the 8-week treatment serves as the active comparator. During the study, participants will have periodic blood tests using qualitative PCR to monitor parasite levels from the end of treatment up to 12 months afterward. Safety will be assessed by tracking adverse events and treatment interruptions. Researchers will also observe patient adherence to treatment in each group. Overall participation includes treatment and follow-up visits over at least 12 months to evaluate sustained parasite clearance and safety outcomes.

CONDITIONS

Brief Title

Shorter Benznidazole Regimens Compared to the Standard Regimen for Chagas Disease

Research Team

C

Carola Lombas, MD

T

Tayná Marques, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here